Charles Parent
Family Medicine · Kennebunk, MENPI 1619909249
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 616 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,496 and has fallen 98.6% since, to $51 in 2022. Among family medicine clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 616 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Pfizer$925
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$624
- Boehringer Ingelheim$609
- Takeda Pharmaceuticals U.S.A., Inc.$537
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,49898%
- Education$1402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $1,408 |
| AbbVie(2 entities) | 128 | $1,387 |
| Pfizer | 86 | $925 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 45 | $624 |
| Boehringer Ingelheim | 47 | $609 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $537 |
| Novo Nordisk | 38 | $526 |
| GSK | 35 | $516 |
| Lilly USA, LLC | 22 | $318 |
| Merck | 18 | $232 |
| Nestle Healthcare Nutrition Inc. | 14 | $210 |
| Sunovion Pharmaceuticals Inc. | 7 | $151 |
| Johnson & Johnson | 8 | $149 |
| Astellas Pharma US Inc | 3 | $137 |
| Endo Pharmaceuticals Inc. | 7 | $122 |
| Scilex Pharmaceuticals Inc. | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Radius Health, Inc. | 4 | $72 |
| Amgen | 4 | $69 |
| Amarin Pharma, Inc. | 4 | $63 |
| Mylan Specialty L.p. | 4 | $51 |
| Shire North American Group Inc | 3 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Novartis | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Bayer | 1 | $17 |
| Smith+Nephew | 1 | $11 |
How this compares
$8,638 in reported general payments places this provider in the 95th percentile of 466 family medicine providers in Maine.
Other family medicine in Kennebunk
- Cecily CannonKennebunk$14K
- Merrill FarrandKennebunk$862
- Kristy Murray-PulsiferSouth Portland$55K
- Albert HartmanLewiston$33K
- Brian KnightonFreeport$29K
- Edward YoonPortland$27K
- Jennifer FreeseVeazie$19K
- Kohar der SimonianFalmouth$18K
- Jessica Bloom FosterBangor$14K
- Maria AtkinsPortland$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.